These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 7635446)
1. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Costa MJ; McIlnay KR; Trelford J Hum Pathol; 1995 Aug; 26(8):829-37. PubMed ID: 7635446 [TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease. Costa MJ; Walls J; Trelford JD Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770 [TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Bell KA; Kurman RJ Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848 [TBL] [Abstract][Full Text] [Related]
5. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872 [TBL] [Abstract][Full Text] [Related]
6. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Taylor J; McCluggage WG Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110 [TBL] [Abstract][Full Text] [Related]
7. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193 [TBL] [Abstract][Full Text] [Related]
8. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities? Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309 [TBL] [Abstract][Full Text] [Related]
9. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy. Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330 [TBL] [Abstract][Full Text] [Related]
10. RETRACTED ARTICLE: Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases. Stolnicu S; Hoang L; Hanko-Bauer O; Barsan I; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA Mod Pathol; 2019 Feb; 32(2):269-279. PubMed ID: 30258209 [TBL] [Abstract][Full Text] [Related]
11. Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas. Wong RW; Ng JHY; Han KC; Leung YP; Shek CM; Cheung KN; Choi CKM; Tse KY; Ip PPC Mod Pathol; 2021 Jan; 34(1):207-221. PubMed ID: 32699256 [TBL] [Abstract][Full Text] [Related]
12. Cytological aspects of uterine cervical adenocarcinoma, adenosquamous carcinoma and combined adenocarcinoma-squamous carcinoma: appraisal of diagnostic criteria for in situ versus invasive lesions. Hayes MM; Matisic JP; Chen CJ; Mohamed A; Anderson GH; LeRiche JC; Amy R Cytopathology; 1997 Dec; 8(6):397-408. PubMed ID: 9439892 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy. Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497 [TBL] [Abstract][Full Text] [Related]
14. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [TBL] [Abstract][Full Text] [Related]
20. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]